Axq Capital »

Cytek Biosciences shares owned by Axq Capital

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Axq Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $97k 19k 5.05

More positions owned by Axq Capital

Bellring Brands Common Stock (BRBR)
Rocket Cos Com Cl A (RKT)
O'reilly Automotive (ORLY)
UnitedHealth (UNH)
Microsoft Corporation (MSFT)
Xylem (XYL)
Sofi Technologies (SOFI)
Duolingo Cl A Com (DUOL)
Marsh & McLennan Companies
Honeywell International (HON)
Blackrock (BLK)
Stryker Corporation (SYK)
NVIDIA Corporation (NVDA)
Interactive Brokers Group In Com Cl A (IBKR)
Lennar Corp Cl A (LEN)

View all positions for Axq Capital

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Robeco Investment Management
State Street Corporation
Millennium Management
Geode Capital Management
Dimensional Fund Advisors
Wellington Management Company
Brown Capital Management
Goldman Sachs Group
Royce & Associates
Charles Schwab Investment Management
AQR Capital Management
Russell Investments

View all funds holding Cytek Biosciences